Detalhe da pesquisa
1.
Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers.
Respirology
; 26(4): 352-359, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33167075
2.
Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data.
Rheumatol Int
; 40(5): 719-726, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32157369
3.
Preclinical lung disease in early rheumatoid arthritis.
Chron Respir Dis
; 13(1): 75-81, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846584
4.
Treatment Considerations of Lung Involvement in Rheumatologic Disease.
Respiration
; 90(4): 265-74, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26461464
5.
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology.
Reumatol Clin (Engl Ed)
; 19(2): 74-81, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35753951
6.
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis.
Sci Rep
; 11(1): 9184, 2021 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33911185
7.
Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive rheumatoid arthritis-related interstitial lung disease.
Semin Arthritis Rheum
; 50(5): 902-910, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32906025
8.
Fatal Pneumonia due to Disseminated Infection by Reactivated Varicella Zoster Virus in a Patient with Interstitial Lung Disease Associated with Rheumatoid Arthritis.
Arch Bronconeumol
; 58(11): 772, 2022 11.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35718578
9.
[Current management in rheumatoid arthritis-related interstitial lung disease]. / Tratamiento actual de la enfermedad pulmonar intersticial asociada a la artritis reumatoide.
Open Respir Arch
; 3(2): 100106, 2021.
Artigo
em Espanhol
| MEDLINE | ID: mdl-37497067
10.
[Development and Validation of a Questionnaire to Assess Knowledge of Asthmatic Disease COAS(GEMPAC) in Adult Patients]. / Desarrollo y validación de un cuestionario para evaluar el conocimiento de enfermedad asmática COAS(GEMPAC) en enfermos adultos.
Open Respir Arch
; 3(3): 100108, 2021.
Artigo
em Espanhol
| MEDLINE | ID: mdl-37496769